Martín Bonacci

机构：Intercept Pharmaceuticals (United States) · ORCID：0000-0002-4528-8066

发表论文 37 篇 · 总被引 759 次 · h-index 11

代表论文

Non-invasive evaluation of response to obeticholic acid in patients with NASH: Results from the REGENERATE study (2021 · Journal of Hepatology · 被引 161)
Long-Term Outcomes of Patients With HCV-Associated Cryoglobulinemic Vasculitis After Virologic Cure (2018 · Gastroenterology · 被引 108)
Obeticholic Acid Impact on Quality of Life in Patients With Nonalcoholic Steatohepatitis: REGENERATE 18-Month Interim Analysis (2021 · Clinical Gastroenterology and Hepatology · 被引 94)
Anti‐viral therapy can be delayed or avoided in a significant proportion of HB eAg‐negative Caucasian patients in the Grey Zone (2018 · Alimentary Pharmacology & Therapeutics · 被引 69)
Hepatitis B reactivation in patients with chronic hepatitis C undergoing anti‐viral therapy with an interferon‐free regimen (2017 · Alimentary Pharmacology & Therapeutics · 被引 51)
Deep-sequencing reveals broad subtype-specific HCV resistance mutations associated with treatment failure (2019 · Antiviral Research · 被引 47)